OncoNano Medicine Appoints Brett Giroir as Chief Executive Officer
Position
Chief Executive Officer
Company
OncoNano Medicine
TexasBiotechnologyHealth CareDescription
OncoNano Medicine has appointed Brett Giroir, M.D., as its new CEO. Giroir recently stepped into the interim CEO role in October before the company made it official.
Quick answer
OncoNano Medicine Appoints Brett Giroir as Chief Executive Officer (November 13, 2026). OncoNano Medicine is based in Texas, United States.
- Who is the new Chief Executive Officer at OncoNano Medicine?
- OncoNano Medicine named Brett Giroir Chief Executive Officer, announced November 13, 2026.
- What did OncoNano Medicine announce on November 13, 2026?
- OncoNano Medicine has appointed Brett Giroir, M.D., as its new CEO. Giroir recently stepped into the interim CEO role in October before the company made it official.
- What does OncoNano Medicine do?
- OncoNano Medicine is a Texas-based biotech developing targeted cancer therapies using proprietary polymer technologies.
- Where is OncoNano Medicine based?
- OncoNano Medicine is based in Texas, United States.
- Which similar companies made leadership changes around the same time?
- GH Research PLC (November 13, 2026), Niki BioSolutions, Inc. (November 13, 2026), Cognito Therapeutics (November 13, 2026) and BioRestorative Therapies (November 12, 2026) also announced leadership changes within 45 days of OncoNano Medicine.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- GH Research PLC Appoints Vanina Popova as Chief Development Officer (November 13, 2026)
- Niki BioSolutions, Inc. names Thomas Freeburg Chief Financial Officer (November 13, 2026)
- Cognito Appoints Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer (November 13, 2026)
- BioRestorative Therapies Appoints David Jenkins as New Director (November 12, 2026)
- Alpha Cognition Inc. Appoints Caren Deardorf as Director (November 12, 2026)
- Wrango Appoints Thomas Shea as Chief Revenue Officer (November 12, 2026)
Who to call at OncoNano Medicine, and when
A new leader at OncoNano Medicine brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day OncoNano Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OncoNano Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OncoNano Medicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OncoNano Medicine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
OncoNano Medicine changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.